CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Cell Line Engineering), By Application (Biomedical, Agricultural), By End Use, By Region, And Segment Forecasts, 2025 - 2030
Shoe Shine Machine Market Growth & Trends
The global shoe shine machine market size is expected to reach USD 99.3 million by 2030, registering a CAGR of 6.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising number of working individuals along with increasing demand for quick shoe cleaning services is projected to drive the demand for shoe polishing machines. In addition, the advent of innovative compact, portable, and automated products with dual cleaning brushes and sensors will dive the demand further. Hands-free operation of these machines is also boosting their demand.
Growing product usage in 5-star hotels, business complexes due to rapidly expanding corporate sector will also have a positive impact on the market growth. The shoe shining machine market in Asia Pacific is anticipated to ascend at the maximum CAGR from 2019 to 2025. This growth is attributed to the rapidly expanding commercial construction sector and number of commercial areas, such as hotels, restaurants, and offices, in the region. In addition, increased consumer purchasing power in emerging countries, such as India and China, is driving the sales for automated shoe polishing products, thereby augmenting market development.
Major companies in the shoe polish machine market follow several strategic initiatives, such as product launches, acquisitions & mergers, and online sales, to expand their geographical reach. For instance, in April 2019, Moneysworth & Best launched its own website for selling their products, which include shoe shine machine, creams, cleaners, soles etc. Some of the prominent industry participants include HEUTE Maschinenfabrik GmbH & Co KG; Beck Shoe Products Co.; Moneysworth & Best; Sunpentown, Inc.; Euronics Industries Pvt. Ltd.; and Dolphy India Pvt. Ltd.
Shoe Shine Machine Market Report Highlights
- The automatic shoe shine machines segment dominated the global industry with a revenue share of 61.7% in 2024. This is attributed to increasing availability and accessibility through online portals and growing demand from commercial buyers such as hotels, airport facilities, facility management organizations, and other hospitality industry participants.
- The commercial application segment held the largest revenue share of this market in 2024, owing to increasing demand from hotels, brick-and-mortar shoe retailers, facility management teams, public rooms, airport facilities, and others.
- North America dominated the global shoe shine machine industry with a revenue share of 37.9% in 2024.
- Asia Pacific shoe shine market is projected to experience the fastest CAGR of 7.6% from 2025 to 2030.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Product & Service Segment
- 1.2.2. Application Segment
- 1.2.3. End Use Segment
- 1.3. Information Analysis
- 1.3.1. Market Formulation & Data Visualization
- 1.4. Data Validation & Publishing
- 1.5. Information Procurement
- 1.5.1. Primary Research
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing Need For Novel Therapeutics
- 3.2.1.2. Rising Demand For Gene Editing
- 3.2.1.3. Rising Incidence Of Cancer
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Off-Target Effects Of CRISPR Technology
- 3.2.2.2. High Cost Factor, Intellectual Property Disputes & Ethical Dilemma
- 3.3. Industry Analysis Tools
- 3.3.1. Porter’s Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
- Chapter 4. Product & Service Business Analysis
- 4.1. Product & Service Segment Dashboard
- 4.2. Global CRISPR And CAS Genes Market: Product & Service Movement Analysis
- 4.3. Global CRISPR And CAS Genes Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
- 4.4. Products
- 4.4.1. Products Market, 2018 - 2030 (USD Million)
- 4.4.2. Kits & Reagents
- 4.4.2.1. Kits & Reagents Market, 2018 - 2030 (USD Million)
- 4.4.2.2. Cas Proteins & Enzymes
- 4.4.2.2.1. Cas Proteins & Enzymes Market, 2018 - 2030 (USD Million)
- 4.4.2.3. Guide RNA
- 4.4.2.3.1. Guide RNA Market, 2018 - 2030 (USD Million)
- 4.4.2.4. Others
- 4.4.2.4.1. Others Market, 2018 - 2030 (USD Million)
- 4.4.3. Libraries
- 4.4.3.1. Libraries Market, 2018 - 2030 (USD Million)
- 4.4.4. Design Tool
- 4.4.4.1. Design Tool Market, 2018 - 2030 (USD Million)
- 4.4.5. Antibodies
- 4.4.5.1. Antibodies Market, 2018 - 2030 (USD Million)
- 4.4.6. Others
- 4.4.6.1. Other Products Market, 2018 - 2030 (USD Million)
- 4.5. Services
- 4.5.1. Services Market, 2018 - 2030 (USD Million)
- 4.5.2. Cell Line Engineering
- 4.5.2.1. Cell Line Engineering Market, 2018 - 2030 (USD Million)
- 4.5.3. gRNA Design & Synthesis
- 4.5.3.1. gRNA Design & Synthesis Market, 2018 - 2030 (USD Million)
- 4.5.4. Screening Services
- 4.5.4.1. Screening Services Market, 2018 - 2030 (USD Million)
- 4.5.5. Others
- 4.5.5.1. Others Market, 2018 - 2030 (USD Million)
- Chapter 5. Application Business Analysis
- 5.1. Application Segment Dashboard
- 5.2. Global CRISPR And CAS Genes Market: Application Movement Analysis
- 5.3. Global CRISPR And CAS Genes Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Biomedical
- 5.4.1. Biomedical Market, 2018 - 2030 (USD Million)
- 5.4.2. Genome Engineering
- 5.4.2.1. Genome Engineering Market, 2018 - 2030 (USD Million)
- 5.4.3. Disease Model Studies
- 5.4.3.1. Disease Model Studies Market, 2018 - 2030 (USD Million)
- 5.4.4. Functional Genomics
- 5.4.4.1. Functional Genomics Market, 2018 - 2030 (USD Million)
- 5.4.5. Epigenetics
- 5.4.5.1. Epigenetics Market, 2018 - 2030 (USD Million)
- 5.4.6. Others
- 5.4.6.1. Other Biomedical Applications Market, 2018 - 2030 (USD Million)
- 5.5. Agricultural
- 5.5.1. Agricultural Market, 2018 - 2030 (USD Million)
- Chapter 6. End Use Business Analysis
- 6.1. End Use Segment Dashboard
- 6.2. Global CRISPR And CAS Genes Market: End Use Movement Analysis
- 6.3. Global CRISPR And CAS Genes Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 6.4. Biotechnology & Pharmaceutical Companies
- 6.4.1. Biotechnology & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
- 6.5. Academic & Government Research Institutes
- 6.5.1. Academic & Government Research Institutes Market, 2018 - 2030 (USD Million)
- 6.6. Contract Research Organizations (CROs)
- 6.6.1. Contract Research Organizations (CROs) Market, 2018 - 2030 (USD Million)
- 6.7. Others
- 6.7.1. Others Market, 2018 - 2030 (USD Million)
- Chapter 7. Regional Business Analysis
- 7.1. Regional Dashboard
- 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 7.3. North America
- 7.3.1. North America CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. U.S. CRISPR And CAS Genes Market, 2018 - 2030 (USD MILLION)
- 7.3.3. Canada
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Canada CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. Mexico CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4. Europe
- 7.4.1. Europe CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. Germany CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.3. UK
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. UK CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. France CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Italy CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Spain CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. Denmark CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Competitive Scenario
- 7.4.8.3. Regulatory Framework
- 7.4.8.4. Sweden CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key Country Dynamics
- 7.4.9.2. Competitive Scenario
- 7.4.9.3. Regulatory Framework
- 7.4.9.4. Norway CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Japan CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. China CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. India CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Competitive Scenario
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. South Korea CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.5.6. Australia
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Australia CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.5.7. Thailand
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. Thailand CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Brazil CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Argentina CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.7. MEA
- 7.7.1. MEA CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. South Africa CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Saudi Arabia CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. UAE CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Kuwait CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Participant Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2024
- 8.4. Company Profiles/Listing
- 8.4.1. Thermo Fisher Scientific
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.1.3. Product/Service Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Illumina
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.2.3. Product/Service Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Agilent Technologies
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.3.3. Product/Service Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Synthego
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.4.3. Product/Service Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Danaher
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.5.3. Product/Service Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Origene Technologies
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.6.3. Product/Service Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. GenScript
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.7.3. Product/Service Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. Lonza
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.8.3. Product/Service Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Revvity, Inc.
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.9.3. Product/Service Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Merck KGaA
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.10.3. Product/Service Benchmarking
- 8.4.10.4. Strategic Initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook